Yonghe Medical Group Co (FRA:L97) Stock Based Compensation: €0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L97 Yonghe Medical Group Co Ltd FRA:L97
84 GF Score
Price €0.27
GF Value €0.21
! 7 Warning Signs
View Full Analysis

What is Yonghe Medical Group Co Stock Based Compensation?

Yonghe Medical Group Co FRA:L97 +3.88% 84 Stock Based Compensation is €0.0 Mil as of Jun. 2026. GuruFocus rates FRA:L97 with a GF Score™ of 84/100 and a GF Value™ of €0.21. The stock has 7 warning signs investors should review.

Yonghe Medical Group Co's Stock Based Compensation for the six months ended in Jun. 2026 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was €0.0 Mil.

Yonghe Medical Group Co Stock Based Compensation Related Terms

Yonghe Medical Group Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Yonghe Medical Group Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co Stock Based Compensation Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 0.03 0.03 0.02 0.02 0.01

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:L97
84GF Score
Yonghe Medical Group Co Ltd FRA:L97
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yonghe Medical Group Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

What does a Stock Based Compensation of €0.0 Mil mean?
Yonghe Medical Group Co (FRA:L97) has a Stock Based Compensation of €0.0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Yonghe Medical Group Co and its competitors.
Is Yonghe Medical Group Co's Stock Based Compensation too high?
Yonghe Medical Group Co's current Stock Based Compensation is €0.0 Mil. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Stock Based Compensation compare to HCA and THC?
Yonghe Medical Group Co's Stock Based Compensation of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Yonghe Medical Group Co and its competitors. Yonghe Medical Group Co's current Stock Based Compensation is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (FRA:L97) has a current Stock Based Compensation of €0.0 Mil. The stock's GF Value™ is €0.21, compared to a current price of €0.27 — trading 27.6% above its estimated fair value. The current Stock Based Compensation is €0.0 Mil. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Yonghe Medical Group Co (FRA:L97), the current Stock Based Compensation is €0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yonghe Medical Group Co (FRA:L97) Overvalued in 2026?

Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued. The current stock price of €0.27 is trading 27.6% above its estimated GF Value™ of €0.21.

Key valuation signals for FRA:L97:

  • Stock Based Compensation: €0.0 Mil
  • GF Value™: €0.21 vs. price of €0.27 (27.6% above fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the FRA:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Yonghe Medical Group Co Business Description

Other Exchanges 02279:Hong Kong
Address Office Tower No. 12B, Chaowai Street, 16th Floor, KunTai International Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score

Get the complete analysis for FRA:L97

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.21
GF Value